Therapeutic implications from sensitivity analysis of tumor angiogenesis models
about
New perspectives in glioblastoma antiangiogenic therapyModel driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasisA computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current.Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data.Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone.The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis
P2860
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@ast
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@en
type
label
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@ast
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@en
prefLabel
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@ast
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@en
P2860
P1433
P1476
Therapeutic implications from sensitivity analysis of tumor angiogenesis models
@en
P2093
Philip Hahnfeldt
P2860
P304
P356
10.1371/JOURNAL.PONE.0120007
P407
P577
2015-03-18T00:00:00Z